HL7 Terminology
1.0.0 - Publication

This page is part of the HL7 Terminology (v1.0.0: Release) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Multum Lexicon - XML Representation

(back to description)

Raw xml

Source view


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="multum"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><h2>Multum Lexicon</h2><div><p>Broadly, the fields and values in the Multum Lexicon and the VantageRx Database are intended to be available for use in any HL7 message that includes a reference to non-veterinary drug products or active ingredients that are either approved for sale by the FDA or readily available in the United States. The following inter-related definitions recently circulated by us to the HL7 Vocabulary Technical Committee explain the scope of what we mean by &quot;drug product&quot; and &quot;active ingredient&quot;. (A definition for &quot;drug ingredient&quot; is also provided here because the definition of &quot;active ingredient&quot; is reliant on this term.)</p>
<p>Drug Product A drug product is a manufactured or extemporaneously-compounded physiologically-active material intended by the preparer to achieve therapeutic, diagnostic, or preventative effects via biochemical mechanisms when applied to an epithelial surface or placed in an internal body space of a targeted organism.</p>
<p>Drug Ingredient A drug ingredient is a chemical compound or biologic agent that occurs in a drug product.</p>
<p>Active Ingredient An active ingredient is a drug ingredient that mediates one or more of the intended therapeutic, diagnostic, or preventative effects of a drug product and is present in sufficient quantities to achieve such effects according to the allopathic tradition of healthcare practice.</p>
</div><p>This code system http://terminology.hl7.org/CodeSystem/multum defines many codes, but they are not represented here</p></div>
  </text>
  <url value="http://terminology.hl7.org/CodeSystem/multum"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.6.27"/>
  </identifier>
  <version value="2.0.0"/>
  <name value="Multum"/>
  <title value="Multum Lexicon"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2019-03-20T00:00:00-04:00"/>
  <publisher value="TBD - External Body"/>
  <description
               value="Broadly, the fields and values in the Multum Lexicon and the VantageRx Database are intended to be available for use in any HL7 message that includes a reference to non-veterinary drug products or active ingredients that are either approved for sale by the FDA or readily available in the United States. The following inter-related definitions recently circulated by us to the HL7 Vocabulary Technical Committee explain the scope of what we mean by &quot;drug product&quot; and &quot;active ingredient&quot;. (A definition for &quot;drug ingredient&quot; is also provided here because the definition of &quot;active ingredient&quot; is reliant on this term.)

Drug Product A drug product is a manufactured or extemporaneously-compounded physiologically-active material intended by the preparer to achieve therapeutic, diagnostic, or preventative effects via biochemical mechanisms when applied to an epithelial surface or placed in an internal body space of a targeted organism.

Drug Ingredient A drug ingredient is a chemical compound or biologic agent that occurs in a drug product.

Active Ingredient An active ingredient is a drug ingredient that mediates one or more of the intended therapeutic, diagnostic, or preventative effects of a drug product and is present in sufficient quantities to achieve such effects according to the allopathic tradition of healthcare practice."/>
  <content value="not-present"/>
</CodeSystem>